Diagnostics & Tech
The acquisition of Texas-based MediSure Laboratory establishes the science and research side of Empower.
Our High Complexity CLIA and COLA accredited lab is active in COVID-19 testing, RT-PCR testing and serology testing with the capacity to process 4,000 RT-PCR test specimens per day.
RESEARCH & DEVELOPMENT
MediSure Laboratory through its scientists and researchers is developing novel diagnostic and test protocols to address the combination of COVID-19, Influenza A and Influenza B.
The MediSure Laboratory ABC PCR test launched Q4 2020.
MediSure Laboratory completed clinical trials, laboratory analysis and validation of the API Pharma Rapid COVID-19 Antigen test submitted to the FDA for approval for use in the US and has submitted a Health Canada application.
The tests are developed with the highest of standards and meet CDC, Health Canada and FDA guidelines for distribution and sale.
Demand for this novel test is high and will be sold through partners serving the public sector and the medical community throughout North America.
MediSure Laboratory has developed a Saliva PCR test for at home specimen collection to detect COVID-19 and Influenza A/B with end user comfort in mind.